US EditionSen. Josh Hawley Amps up Pressure Campaign on FDA Chief to Limit Medication Abortion
Sen. Hawley demands FDA clarify if a full safety review of mifepristone is underway and respond by Dec. 15 amid concerns over delayed evaluation and prescribing rules.
- On Wednesday, Missouri U.S. Sen. Josh Hawley sent a two-page letter to FDA Commissioner Marty Makary demanding the agency finish a medication-abortion study and reply before Dec. 15.
- Hawley's letter followed calls from anti-abortion leaders who urged President Donald Trump to fire Makary after a Bloomberg Law report suggested a review delay.
- Hawley demanded answers to three questions, specifically asking if the FDA is conducting a comprehensive safety review of mifepristone separate from REMS, if any reviews were delayed, and if in-person dispensing will return.
- Mifepristone's current approval up to 10 weeks means prescribing changes could limit access nationwide, as it is available via telehealth and shipping and major groups report adverse events under 0.32%.
- HHS defended the pace of the review, saying FDA evaluations take necessary time, while John Mize, Americans United for Life CEO, said political calculations stalled the process and President Donald Trump said `I don't think they're slow walking anything, but I'll find out.
20 Articles
20 Articles
Springfield News-Leader
MO Sen. Josh Hawley pressures FDA chief to limit medication abortion
Hawley and other anti-abortion groups and legislators say the health organization is "slow-walking" a review of the drug mifepristone.
Sen Josh. Hawley amps up pressure on FDA chief to limit medication abortion
U.S. Sen. Josh Hawley, R-Mo., talks to reporters at the U.S. Capitol on Saturday, June 28, 2025. (Photo by Ashley Murray/States Newsroom)WASHINGTON — Missouri U.S. Sen. Josh Hawley is ratcheting up pressure on the U.S. Food and Drug Administration to finish a study into medication abortion and to change its prescribing guidelines, sending a letter to Commissioner Marty Makary on Wednesday that the pace of the review is “totally unacceptable.” Th…
Missouri Sen. Hawley amps up pressure campaign on FDA chief to limit medication abortion • SC Daily Gazette
U.S. Sen. Josh Hawley, R-Mo., talks to reporters at the U.S. Capitol on Saturday, June 28, 2025. (Photo by Ashley Murray/States Newsroom)WASHINGTON — Missouri U.S. Sen. Josh Hawley is ratcheting up pressure on the U.S. Food and Drug Administration to finish a study into medication abortion and to change its prescribing guidelines, sending a letter to Commissioner Marty Makary on Wednesday that the pace of the review is “totally unacceptable.” Th…
Senator Hawley Hates Abortion Pills
Context . . .The number of U.S. abortions keep rising and recent studies suggest that 63% of all women now rely on abortion pills to terminate pregnancies. Our perspective here is gloomy but we find that this axiom holds true: Limiting technology is nearly impossible this might be a losing battle given that even the most strident Republican women often vote for abortion access by way of secret ballot. Remember that even Red State Missouri voter…
Coverage Details
Bias Distribution
- 89% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
